Aug 2026· Journal of Infection and Public Health· Vol 19 10, pp.
103334
· 0 citations· 34 references
Medicine
TL;DR
This study provides new resources concerning the SARS-CoV-2 variants circulating in West and Central Africa between 2020 and 2022, which are less represented in global datasets.
Abstract
Objective
The study aims to identify and characterize the SARS-Cov-2 variants circulating in West and Central Africa during the pandemic, between 2020 and 2022.
Methods
From early 2020 to late 2022, naso-pharyngeal or oro-pharyngeal samples were collected in five countries: Burkina Faso, Côte d'Ivoire, Mali, Republic of Congo and Chad. SARS-CoV-2 positive samples (Ct-value < 30) were sequenced to identify the circulating variants in these countries during the different waves of the pandemic.
Results
Overall, 793 whole genomes of SARS-Cov-2 were generated: 308 in Côte d'Ivoire, 244 in the Republic of Congo, 91 in Chad, 87 in Burkina Faso and 63 in Mali. In 2020, early variants detected included B.1 and B.1.1. Lineage A.21 was identified in both Burkina Faso and Mali, while lineages A and A.18 were detected in Côte d'Ivoire and Mali. Some variants appeared to be country-specific, such as lineage B.1.1.404 in Burkina Faso. Chad exhibited a distinct pattern compared with the other countries, with Delta variants detected earlier than in the other locations. In 2021, the diversity of circulating variants increased and differed more markedly between countries. In 2022, the variant landscape was dominated by Omicron lineages in all countries.
Conclusion
This study provides new resources concerning the SARS-CoV-2 variants circulating in West and Central Africa between 2020 and 2022, which are less represented in global datasets. The variants identified in this study were similar to the variants observed in other regions of the world.
SARS-CoV-2 subvariants continue to circulate sporadically in Guinea, with the XFJ recombinant having been detected in humans, and it is imperative to strengthen sentinel, genomic, and environmental surveillance for the early detection of any new COVID-19 outbreak and the potential emergence of new variants.
M. Keita, Bassala Traoré, Houssainatou Bah et al.· The Pan African Medical Jour...· 0 citations
The epidemiology, virological properties, and characteristic features of different sub-lineages of Omicron, which have been dominated throughout the year 2023 in the Indian population are investigated.
Amrita Panja, Biplab Kahar· Asian Journal of Medical Sci...· 0 citations
This study helps to understand the SARS-CoV-2 evolution and dynamics in Niger Republic, where diagnostic capacities and containment measures were challenging.
A. Lagaré, Issaka Aboubacar Adakal, A. Yacouba et al.· Infection, Genetics and Evol...· 0 citations
While SARS-CoV-2-positive NPS displayed several waves, including substantial peaks in mid-2022 and mid-2023 and subsequent winter peaks, each linked to the establishment or replacement of dominant Omicron lineages, testing volumes indicated recurrent winter rises.
Zaineb Hamzaoui, S. Ferjani, Takoua Bouchouicha et al.· Virology Journal· 0 citations
This study demonstrates that SARS-CoV-2 continues to circulate in coastal Kenya causing predominantly mild upper respiratory illness while evolution enabling immune escape, and emphasizes the importance of integrated genomic and immunological surveillance to track emerging variants, evaluate population-level protection...
Gloria Konyino, B. Kutima, Sharon Owuor et al.· Frontiers in Cellular and In...· 0 citations
Tracking SARS-CoV-2 variants revealed the predominance of the JN.1 sublineage of Omicron with generally mild symptoms, highlighting the need for robust, ongoing genomic surveillance integrated with epidemiological data to enable early detection of emerging variants and strengthen control strategies.
P. Rao, S. Ganju, L. R. Chandel· Journal of Clinical and Diag...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.